One-way and two-way sensitivity analyses of point-of-care CD4 test characteristics on misclassification of patients, clinical outcomes, costs, and cost-effectiveness compared to laboratory-based CD4 tests.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_One_way_and_two_way_sensitivity_analyses_of_point_of_care_CD4_test_characteristics_on_misclassification_of_patients_clinical_outcomes_costs_and_cost_effectiveness_compared_to_laboratory_based_CD4_tests_/1171356
下载链接
链接失效反馈官方服务：
资源简介：
Base case in bold.aDerived using test performance of percent SD = 32.6% [36], mean CD4 count (SD) of cohort = 300/µl (230/µl), and ART-eligibility threshold at CD4 count ≤250/µl,bFalse positives: patients who are ART ineligible (true CD4 count>250/µl) but are misclassified as ART eligible.cFalse negatives: patients who are ART eligible (true CD4 count ≤250/µl) but are misclassified as ART ineligible.dDiscounted at 3%/y.One-way and two-way sensitivity analyses of point-of-care CD4 test characteristics on misclassification of patients, clinical outcomes, costs, and cost-effectiveness compared to laboratory-based CD4 tests.
创建时间：
2015-12-02
